1. Home
  2. FWONA vs VTRS Comparison

FWONA vs VTRS Comparison

Compare FWONA & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Media Corporation Series A Liberty Formula One

FWONA

Liberty Media Corporation Series A Liberty Formula One

HOLD

Current Price

$90.89

Market Cap

20.0B

Sector

Industrials

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$16.70

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWONA
VTRS
Founded
1950
1961
Country
United States
United States
Employees
1674
30000
Industry
Broadcasting
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.0B
18.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FWONA
VTRS
Price
$90.89
$16.70
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$101.75
$13.50
AVG Volume (30 Days)
146.3K
9.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
3.21%
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$24.56
$4.41
Revenue Next Year
$5.52
$1.96
P/E Ratio
$97.75
$111.27
Revenue Growth
N/A
N/A
52 Week Low
$73.70
$8.63
52 Week High
$99.49
$17.53

Technical Indicators

Market Signals
Indicator
FWONA
VTRS
Relative Strength Index (RSI) 73.28 60.18
Support Level $84.51 $16.02
Resistance Level $91.04 N/A
Average True Range (ATR) 2.45 0.48
MACD 0.88 0.05
Stochastic Oscillator 89.07 97.78

Price Performance

Historical Comparison
FWONA
VTRS

About FWONA Liberty Media Corporation Series A Liberty Formula One

Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. It operates in two reportable segment Formula 1 and MotoGP. It generates majority of its revenue from the Formula 1 segment. The company derives its maximum revenue from United Kingdom.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: